Phenyltetrazolyl-phenylamides: Substituent impact on modulation capability and selectivity toward the efflux protein ABCG2 and investigation of interaction with the transporter

被引:16
作者
Koehler, Sebastian C. [1 ]
Silbermann, Katja [1 ]
Wiese, Michael [1 ]
机构
[1] Rhein Friedrich Wilhelms Univ Bonn, Inst Pharmazeut, Immenburg 4, D-53121 Bonn, Germany
关键词
ABC-transporter; ABCG2; BCRP inhibitor; Synthesis; Structure-activity relationship; Enzyme kinetics; MULTIDRUG-RESISTANCE TRANSPORTER; DRUG EFFLUX; CANCER; INHIBITORS; CHALCONES; POTENT; DERIVATIVES; BCRP/ABCG2; MECHANISM; PATTERN;
D O I
10.1016/j.ejmech.2016.09.010
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We recently presented a novel class of ABCG2 modulators based on the third-generation ABCB1 inhibitor tariquidar bearing a 2,5-linked tetrazole instead of an amid linker. We investigated the modulating potential of the compound class by enlarging the substitution pattern on the outer phenyl rings of the scaffold. To identify the structural conditions for achieving a high response, we decided to determine the individual influence of substituents on the scaffold using monosubstituted derivatives. While electron withdrawing groups (with a few exceptions) and bulky moieties decreased the modulating potency, small electron donating groups ensured a high activity level. Interestingly, the unsubstituted derivative 32 reached a similar inhibitory potential as the best derivatives in the previous study. Enzyme kinetic assays indicated that our derivatives have the same binding site as reference inhibitor Ko143. They were found to interact competitively and non-competitively with the substrates Hoechst 33342 and pheophorbide A, respectively. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:881 / 895
页数:15
相关论文
共 51 条
[11]   ABC transporters in cancer: more than just drug efflux pumps [J].
Fletcher, Jamie I. ;
Haber, Michelle ;
Henderson, Michelle J. ;
Norris, Murray D. .
NATURE REVIEWS CANCER, 2010, 10 (02) :147-156
[12]   Strategies for reversing drug resistance [J].
Fojo, T ;
Bates, S .
ONCOGENE, 2003, 22 (47) :7512-7523
[13]   Phenolic indeno[1,2-b]indoles as ABCG2-selective potent and non-toxic inhibitors stimulating basal ATPase activity [J].
Gozzi, Gustavo Jabor ;
Bouaziz, Zouhair ;
Winter, Evelyn ;
Daflon-Yunes, Nathalia ;
Honorat, Mylene ;
Guragossian, Nathalie ;
Marminon, Christelle ;
Valdameri, Glaucio ;
Bollacke, Andre ;
Guillon, Jean ;
Pinaud, Noel ;
Marchivie, Mathieu ;
Cadena, Silvia M. ;
Jose, Joachim ;
Le Borgne, Marc ;
Di Pietro, Attilio .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 :3481-3495
[14]   ABC TRANSPORTERS - FROM MICROORGANISMS TO MAN [J].
HIGGINS, CF .
ANNUAL REVIEW OF CELL BIOLOGY, 1992, 8 :67-113
[15]   ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules organisms from bacteria to humans [J].
Holland, IB ;
Blight, MA .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 293 (02) :381-399
[16]   Cancer drug resistance: an evolving paradigm [J].
Holohan, Caitriona ;
Van Schaeybroeck, Sandra ;
Longley, Daniel B. ;
Johnston, Patrick G. .
NATURE REVIEWS CANCER, 2013, 13 (10) :714-726
[17]  
Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI [10.3322/caac.20006, 10.3322/caac.21254, 10.3322/caac.21332, 10.3322/caac.21551, 10.3322/caac.20073, 10.3322/caac.21387, 10.3322/caac.21654, 10.3322/caac.21601]
[18]   Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2) [J].
Juvale, Kapil ;
Gallus, Jennifer ;
Wiese, Michael .
BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (24) :7858-7873
[19]   Synthesis and biological evaluation of flavones and benzoflavones as inhibitors of BCRP/ABCG2 [J].
Juvale, Kapil ;
Stefan, Katja ;
Wiese, Michael .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 67 :115-126
[20]   Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein [J].
Juvale, Kapil ;
Pape, Veronika F. S. ;
Wiese, Michael .
BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (01) :346-355